Intrathecal inflammation precedes development of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Intrathecal inflammation precedes development of Alzheimer's disease

Intrathecal inflammation precedes development of Alzheimer's disease

http://www.wikidata.org/entity/Q35476365

about

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.The role of macrophage migration inhibitory factor in Alzheimer's disease Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease TNF-α/NF-κB signaling in the CNS: possible connection to EPHB2 Innate immunity in Alzheimer's disease: a complex affair Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Oral TNFα Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan Neuroinflammation in Alzheimer's disease Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.Glial contributions to neurodegeneration in tauopathies.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis Tumor necrosis factor α Inhibition for Alzheimer's Disease.Biomarkers of oxidative damage and inflammation in Alzheimer's disease.Presenilin 2 is the predominant γ-secretase in microglia and modulates cytokine release Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease.Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.Transcription factor p53 influences microglial activation phenotype Increased production of inflammatory cytokines in mild cognitive impairment.Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia.Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.

P2860

Q21261380-3CBD705B-6F53-4CD9-B252-729DB17150F9 Q24634765-62C8002A-D5A0-47F2-9E8F-F923FEB60325 Q24652684-6F37F0F2-640B-4403-958C-2A7D132963B6 Q24681139-333B24B2-813D-41BA-B9C5-F7105E9EEB7F Q24814434-8E28FB01-E63C-4273-A2D4-D2A6B5284EC2 Q26799870-FD3157A2-23E7-4803-A0C5-2D8EE28E50DB Q26828831-62CE3721-C1C9-4C0C-9656-EED3BBAFEC5E Q27006944-FC40D19F-EE88-46C4-89E6-CBC5C31727B4 Q27027319-A5F9D5EA-CD0C-4AEE-A171-596D81FC3AEA Q27319559-D311A326-478B-4588-B0F7-7696D1B19A9A Q28075692-C526BF68-6ADD-459A-95B1-6026E3ED1435 Q28087176-43CD5405-2C4B-447B-B3F7-CE71152ABB11 Q28245638-63F7C4E4-13EF-4E4B-9B97-4A18609D89D9 Q28259238-CC351C6D-28EC-4B47-9414-0739F1291D8F Q28488088-C3AD7470-F3EF-4DC0-A024-DAD8A23F269A Q30415876-5F6F5B1F-F0F2-4F72-A8CC-798B7EA7393A Q30481096-32DA3564-A182-4969-87AC-7821D932627E Q32173558-D1DF7137-CA74-4FF7-9C11-3B4F920ADA9B Q33237201-2C01F72F-9FBA-4ECB-B555-967FBA085211 Q33417987-2EC62E59-3C63-4B9B-B164-6FC5F25D3F72 Q33551339-6316DBEC-871A-4C06-9BF4-03B0DCCA9A3D Q33704278-DAC01D70-5242-4982-BE88-AF5909746BED Q33771834-A30139DB-A143-4DA8-A783-1BE3E6A1B353 Q33785755-18D2FF33-87CD-4FAE-B7FB-AEA5FBB6BB0E Q33947639-CCAF8DD8-9813-40FD-8F14-DBB6C9D24C7F Q34129473-9A980155-4594-4A9F-897C-D696FB6AF6D4 Q34201803-CAF898F0-ABB8-406E-8AE3-901C187B9ECF Q34277859-A83E9E80-FD2F-4935-9202-B9515CF12A48 Q34475359-ED01B881-A040-453C-9D90-59EEBF817A39 Q34584102-E329D119-F99F-4669-A170-B9287E27D46A Q34760173-410530E7-AEC8-4FB0-9D2B-82D3BD814C29 Q35016567-CC8309EB-7212-4D3E-AABF-A20A1362935F Q35127007-3D526225-D96F-48A6-BB47-FD26680D557E Q35792619-1F31657E-2D2D-48A7-95FE-64B233D52B72 Q35954373-EA48867D-40D6-4E77-A706-9E9CECE5D39E Q35990600-3F468D77-9BFD-4A74-ADE8-343C46354401 Q36109443-B894B787-29CF-4B36-B71F-9B1A4CB1A1EB Q36112435-41E601E2-F4D6-4477-81CD-19B6E5B1E5B6 Q36118204-FD20D238-4840-4271-AEA7-5FF95A2EDF10 Q36119066-A29E3718-19FB-4ECE-ADBB-2558C55A05CF

P2860

Intrathecal inflammation precedes development of Alzheimer's disease

http://www.wikidata.org/entity/Q35476365

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Intrathecal inflammation precedes development of Alzheimer's disease

@ast

Intrathecal inflammation precedes development of Alzheimer's disease

@en

type

label

Intrathecal inflammation precedes development of Alzheimer's disease

@ast

Intrathecal inflammation precedes development of Alzheimer's disease

@en

prefLabel

Intrathecal inflammation precedes development of Alzheimer's disease

@ast

Intrathecal inflammation precedes development of Alzheimer's disease

@en

P1433

Q35476365-6250717B-341E-4613-8FF6-896F034E6592

P1476

Q35476365-89B4C208-0206-4DF4-B8EB-7CF7B6700022

P2093

Q35476365-1241F3FD-D707-46FD-9E56-44C2E5D5FD9C

Q35476365-7A5737BB-7CC1-489D-A170-2B11B7CDC805

Q35476365-BC57493D-0DA9-496F-B82F-73C07BD73A73

P2860

Q35476365-019E8A74-C972-4077-8F44-5532D23CB8A4

Q35476365-03AF34BD-512A-4759-A5A7-2318C079C15F

Q35476365-0B0E8D6D-C641-420E-AE1C-742D399F80C9

Q35476365-0D1AE301-9D9E-4B01-B110-1405C46D72C1

Q35476365-25B10083-DB79-42B8-9499-B5DF49E48F77

Q35476365-29E70149-8B3F-48F0-8C55-7B0057B0343F

Q35476365-32809EC7-146C-478A-A32D-3C436E3084B5

Q35476365-334BFC2E-7741-494D-9A8E-6B5B3BBDB446

Q35476365-3453FC65-CBEA-4AEC-8CCB-D5C221C5E1E2

Q35476365-3E14FE7E-CE0E-4F17-B026-38E374C92F15

P304

Q35476365-B0149771-8EAC-459E-841B-C7430564DDA8

P31

Q35476365-332D1E22-B05B-4BA4-B632-7BE7717157CB

P356

Q35476365-8F8E8110-E1F9-4090-A68C-1FBE783BA61B

P407

Q35476365-9FB91550-32E6-43D3-95FF-4F0F1E5FA754

P433

Q35476365-734434DC-FBF7-4280-B422-72D2BFF3F6BA

P478

Q35476365-6F5E9E3B-2AFB-49A1-BAAE-2E9B02573413

P50

Q35476365-C84AA9A5-7750-431C-A2DB-BBBB7552F865

P577

Q35476365-B59B6D08-FA87-48D7-AFE1-6CE0123B6DCA

P5875

Q35476365-7AE7409B-38EC-4A77-A342-08DC72EB726B

P698

Q35476365-5F054399-72C3-4A34-8ABF-26133D29E1F8

P921

Q35476365-0125308F-AD73-48BB-B3E3-70BCCD284883

Q35476365-F97D6656-7B45-481D-813F-8616B5632C08

P932

Q35476365-C9FBA80C-9F94-43F0-A96F-415AC5766C47

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Intrathecal inflammation precedes development of Alzheimer's disease

@en

P2093

Andreasen N

http://www.w3.org/2001/XMLSchema#string

Tarkowski A

http://www.w3.org/2001/XMLSchema#string

Tarkowski E

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Inflammation and Alzheimer's disease

Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

Localization of interleukin-1 receptor antagonist mRNA in rat brain.

The participation of interleukin-6 in the pathogenesis of Alzheimer's disease.

P304

1200-1205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.74.9.1200

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10601355

http://www.w3.org/2001/XMLSchema#string

P698

12933918

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1738668

http://www.w3.org/2001/XMLSchema#string